Scholarlink

<p>Myo-inositol (mI) and total N-acetylaspartate (tNAA) are potential MR spectroscopic imaging (MRSI) biomarkers of smouldering-associated worsening in multiple sclerosis (MS). In this study, we explored metabolic changes in normal-appearing white matter (NAWM) in patients with relapsing–remitting MS (pwRRMS) using 7&#xa0;T MRSI. 20 pwRRMS were scanned annually with 2D-MRSI, with follow-up ranging up to three years. Metabolic ratios were calculated within NAWM for each measurement and assessed cross-sectionally and longitudinally with established and emerging MRI measures of disease burden, including paramagnetic rim lesions (PRLs), brain atrophy, and T2 lesion load. At baseline, pwRRMS showed higher mI/tNAA (β = 0.058; <i>p</i> = 0.047) and lower tNAA/total creatine (tCr) (β = − 0.106; <i>p</i> = 0.029) compared to controls. tNAA/tCr was further reduced in pwRRMS with PRLs (β = − 0.138; <i>p</i> = 0.022). mI/tNAA was associated negatively with cerebral WM volume (β = − 0.001, <i>p</i> = 0.015) and positively with T2 lesion volume (β = 0.009; <i>p</i> = 0.044). mI/tNAA increased longitudinally in pwRRMS (β = 0.014; <i>p</i> = 0.022), especially with higher PRL count (β<sub>timepoint:PRLcount</sub> = 0.016; <i>p</i> = 0.045). An association between tNAA/tCr and the interaction of time with total GM volume was observed but did not survive FDR-correction (β = 0.001; <i>p</i> = 0.078). These findings further support the clinical relevance of mI and tNAA alterations as imaging biomarkers of underlying pathology in MS. They highlight the value of 7&#xa0;T MRSI in capturing subclinical disease burden and underscore the association of PRLs with overall widespread WM damage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Metabolic changes in normal-appearing white matter associate with MRI measures of disease burden in relapsing-remitting multiple sclerosis over three years

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月24日

查看全文
  • Anna Zöchner,
  • Wolfgang Bogner,
  • Assunta Dal-Bianco,
  • Bernhard Strasser,
  • Gilbert Hangel,
  • Paulus Stefan Rommer,
  • Eva Niess

摘要

Myo-inositol (mI) and total N-acetylaspartate (tNAA) are potential MR spectroscopic imaging (MRSI) biomarkers of smouldering-associated worsening in multiple sclerosis (MS). In this study, we explored metabolic changes in normal-appearing white matter (NAWM) in patients with relapsing–remitting MS (pwRRMS) using 7 T MRSI. 20 pwRRMS were scanned annually with 2D-MRSI, with follow-up ranging up to three years. Metabolic ratios were calculated within NAWM for each measurement and assessed cross-sectionally and longitudinally with established and emerging MRI measures of disease burden, including paramagnetic rim lesions (PRLs), brain atrophy, and T2 lesion load. At baseline, pwRRMS showed higher mI/tNAA (β = 0.058; p = 0.047) and lower tNAA/total creatine (tCr) (β = − 0.106; p = 0.029) compared to controls. tNAA/tCr was further reduced in pwRRMS with PRLs (β = − 0.138; p = 0.022). mI/tNAA was associated negatively with cerebral WM volume (β = − 0.001, p = 0.015) and positively with T2 lesion volume (β = 0.009; p = 0.044). mI/tNAA increased longitudinally in pwRRMS (β = 0.014; p = 0.022), especially with higher PRL count (βtimepoint:PRLcount = 0.016; p = 0.045). An association between tNAA/tCr and the interaction of time with total GM volume was observed but did not survive FDR-correction (β = 0.001; p = 0.078). These findings further support the clinical relevance of mI and tNAA alterations as imaging biomarkers of underlying pathology in MS. They highlight the value of 7 T MRSI in capturing subclinical disease burden and underscore the association of PRLs with overall widespread WM damage.